Loading decisions…
Loading decisions…
475 vetted Board decisions in 2016.
The Veteran's appeal is being remanded for additional development regarding his claims of service connection and exposure to herbicides. The issues include prostate cancer, tinnitus, right ear hearing loss, and left ear hearing loss.
The Veteran's claims of service connection for prostate cancer and PTSD are being remanded due to the need for a Board hearing.
The Veteran's appeal is being remanded due to the need for additional development, including obtaining VA and private treatment records, scheduling a VA examination, and readjudicating the claims.
The Veteran's residuals of prostate cancer were initially granted with a 20 percent rating effective July 9, 2012. The Board found that the condition warranted a higher initial evaluation from December 3, 2012 to June 11, 2014 (40 percent), and no higher after that date.
The Veteran's transportation expenses incurred on August 9, 2009 were denied because the service-connected disability for which he was transported (prostate cancer) had not yet been established at that time.
The Veteran's prostate cancer is not service-connected due to lack of exposure to herbicides during his active duty in Thailand. The claim for special monthly compensation based on loss of use of a creative organ is also denied.
The Board has remanded the Veteran's claims for bladder cancer, prostate cancer, and renal cell carcinoma due to potential service connection based on exposure at Camp Lejeune. The claims are inextricably intertwined as they all relate to the same exposure issue.
The Veteran's prostate cancer and related residuals are being remanded for further development, including obtaining VA treatment records since April 2013. The precancerous growth on the esophagus is also being remanded but no specific exposure basis or rating assigned was provided.
The Veteran's claims for service connection are being remanded due to the need for clarification regarding his exposure to herbicides and chemicals at Sabana Seca, Puerto Rico.
The Veteran's residuals of prostate cancer are rated at 60 percent, the maximum schedular rating for voiding dysfunction. His diabetes mellitus, type II, is currently rated at 20 percent and does not meet the criteria for a higher initial rating.
The Veteran's claim for accrued benefits based on service connection for prostate, lung and brain cancer due to herbicide exposure is being remanded for additional development as the appellant wishes to determine how her claim should be construed.
The Board has determined that the Veteran's prostate cancer is incurred in active service, and his claim for an acquired psychiatric disorder is granted.
The Veteran's claims for service connection for prostate cancer, malaria, and tinnitus were denied. His claim for compensation under 38 U.S.C.A. � 1151 for a hip replacement was also denied.
The Board has remanded the case for additional development to determine if the Veteran was assigned to temporary duty in the Republic of Vietnam during his service, which could potentially support a claim for secondary service connection for prostate cancer due to herbicide exposure.
The Board has determined that the Veteran's prostate cancer is no longer active as of May 18, 2015 and thus a 100% rating should be assigned until at least six months after any surgical or therapeutic procedures.
The Veteran's claim for TDIU is being remanded due to the need for additional development, including obtaining records from SSA and VA/VA clinics, as well as any private treatment records. A new VA examination will also be scheduled.
The Board found that the Veteran's prostate cancer was not incurred in or aggravated by service, and may not be presumed to have been incurred therein due to exposure to contaminated water at Camp Lejeune.
The Board has remanded the case for a Travel Board hearing and further development.
The Veteran's appeal was dismissed due to his death.
The Veteran's appeals for higher ratings for hearing loss, service connection for prostate cancer, and service connection for leukemia have been dismissed due to the death of the appellant.
← Back to Prostate cancer overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.